Clinical Trials Browser

Recruiting × mirdametinib × 30 days × Clear all

NCT07539441 2026-04-20

A Study of Mirdametinib in People With Central Nervous System Tumors

Phase 1/2 Recruiting

Glioma, Central Nervous System Neoplasms

NCT06159166 2026-04-13

Mirda

Phase 1/2 Recruiting

CNSDermatologic

NF1

NCT07061951 2026-04-13

Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia

Phase 2 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell